Selected stock price target news of the day - January 8th, 2024

By: Matthew Otto

 

Agilon Health Unveils Financial Projections for 2023 and 2024

Agilon Health has released detailed numerical insights into its financial expectations for the fiscal years 2023 and 2024. In the revised guidance for 2023, the company foresees Medicare Advantage membership ranging from 386,000 to 387,000, with total revenues projected between $4,295 million and $4,305 million. However, challenges have led to a shift in the adjusted EBITDA outlook, ranging from ($69) million to ($55) million, alongside geography entry costs estimated at $71 million. Looking forward to 2024, Agilon Health aims to expand its Medicare Advantage membership to 548,000 to 553,000, with an anticipated revenue range of $6,350 million to $6,420 million. The medical margin for 2024 is forecasted to be between $560 million and $600 million, supported by an adjusted EBITDA projection of $40 million to $60 million, and consistent geography entry costs of $70 million.

 

Analysts Downgrade Amid Market Shift

  • Wolfe Research analyst Justin Lake shifted from Outperform to Peer Perform.
  • Truist Securities analyst Jailendra Singh downgraded from Buy to Hold and the price target from $23 to $10.
  • JP Morgan analyst Lisa Gill downgraded from Overweight to Neutral and the price target from $17 to $9.
  • Benchmark analyst Bill Sutherland lowered the price target to $13.
  • RBC Capital analyst Sean Dodge decreased the price target to $11.
  • JMP Securities analyst Constantine Davides adjusted the price target to $11.
  • Leerink Partners analyst Whit Mayo downgraded to Market Perform.

 

Which Analyst has the best track record to show on AGL?

Analyst George Hill (DEUTSCHE BANK) currently has the highest performing score on AGL with 4/11 (36.36%) price target fulfillment ratio. His price targets carry an average of $1 (9.09%) potential upside. Agilon Health stock price reaches these price targets on average within 35 days.

 

 

 

AMD’s AI Growth with TSMC Collaboration

Reports from the United Daily News, industry sources in Taiwan suggest that AMD’s foray into artificial intelligence is closely tied to multiple implementations of TSMC’s advanced 5-nanometer and 6-nanometer semiconductor manufacturing processes. The integration of these processes through TSMC’s cutting-edge packaging technologies positions AMD as a key player in the competitive landscape. Speculations indicate that major AI players, including Microsoft and Meta, may diversify and shift some of their computing hardware to AMD, potentially driving demand for AMD’s MI300 accelerators to reach 400,000 units in 2024 and 600,000 units in 2025. The success of this projection is contingent on TSMC’s ability to scale up its manufacturing capacity.

 

Analyst Updates Ratings and Raised Price Targets

  • Melius Research analyst Ben Reitzes upgraded from Hold to Buy and set a price target of $188.
  • Mizuho analyst Vijay Rakesh maintained a Buy rating and increased the price target from $130 to $162.

 

Which Analyst has the best track record to show on AMD?

Analyst Timothy Arcuri (UBS) currently has the highest performing score on AMD with 5/5 (100%) price target fulfillment ratio. His price targets carry an average of $27.17 (25.20%) potential upside. Advanced Micro Devices stock price reaches these price targets on average within 95 days. 

 

 

Daily stock Analysts Top Price Moves Snapshot